What You Should Know:
- Healthcare solutions company LetsGetChecked, today announced the acquisition of genomics pioneer Veritas Genetics and Veritas Intercontinental.
- Through these acquisitions, LetsGetChecked will leverage the power of whole-genome sequencing to launch a full lifecycle of personalized healthcare, delivering the most comprehensive health testing and care solution on the market.
LetsGetChecked, a leading healthcare solutions company acquires Veritas Genetics Inc.
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
ConcertAI Raises $150M at $1.9 Billion Valuation for RWD Platform
What You Should Know:
- ConcertAI, LLC (ConcertAI), the leader in enterprise AI and real-world data (RWD) solutions for life sciences and healthcare, announced the close of its $150M in Series C led by Sixth Street at a $1.9B valuation.
- From its startup just five years ago, ConcertAI has emerged as one of the fastest-growing companies providing high-value software-as-a-service (SaaS) and data solutions to life sciences and biopharma companies, leading healthcare providers, contract
Read More
CPQ: Optimizing MedTech Operations and Sales to Accelerate Cash Flow
The lead-to-cash process in most B-to-B organizations––particularly those operating in the medical device industry––is often complex and lengthy. This is even more apparent when operations, sales and customer success teams operate in manual and siloed environments.
In this all-too-common scenario, not only does it slow cash flow velocity, it also leaves the organization vulnerable to inconsistencies, inaccuracies and more errors every time a handoff occurs between
Read More
Tempus Launches Pathology-Driven AI Platform
What You Should Know:
- Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain (H&E) slide.
- With access to over 50 petabytes of de-identified multimodal data, Tempus is developing AI models with the aim to identify patients who would
Read More
Applied XL Raises $3.5M for Real-Time Data Tracking Platform
What You Should Know:
- Applied XL, a real-time information company tracking disruptions to the health of people, places, and the planet, today announced it had raised $3.5 million in seed funding led by Hearst Ventures with the participation of the Boston Globe Media Partners and STAT, which are owned by the Henry family.
- The latest round brings Applied XL’s total funds raised to date to $5 million in the last 12 months. The company will use the new funding to scale its first vertical
Read More
physIQ, CellCarta Collaborate on Study to Revolutionize Vaccine
What You Should Know:
- Today, digital medicine leader physIQ and CellCarta, a global leader in precision medicine services announced they are collaborating on a groundbreaking study that could revolutionize vaccine development.
- The strategic collaboration advances the detailed study of early, individualized human responses to vaccinations as pharma companies race to deliver safe, effective vaccines sooner.
physIQ, a pioneer in digital medicine, and CellCarta, a global leader in
Read More
Verily & Lumea Partner to Leverage AI in Prostate Cancer Diagnoses
What You Should Know:
- Verily and Lumea today announced a strategic partnership to develop products that can diagnose, prognose, and guide prostate cancer therapy selection with improved objectivity and efficiency.
- Lumea’s integrated digital pathology solution will validate Verily’s AI method for improving cancer detection and grading in partnership with Google Health.
Partnership Goals
The Verily-Lumea collaboration will utilize Lumea’s digital pathology platform
Read More
Proscia and Siemens Healthineers Expands Global Reach of Digital Pathology
What You Should Know:
- Proscia®, a digital and computational pathology solution announced a multi-year OEM agreement with Siemens Healthineers.
- Under the agreement, Siemens Healthineers will enter the market by combining its Syngo Carbon enterprise imaging solution with Proscia’s Concentriq Dx digital pathology platform.
Read More
Foresite Capital Raises $173M Fund for Foresite Labs Incubated Companies
What You Should Know:
- Foresite Capital is announcing their latest, oversubscribed $173M fund, which will be used to support Foresite Labs’ incubated life science companies.
- Foresite Labs was created in October 2019 to found, build, and scale life sciences companies at the intersection of healthcare and data science. One of Foresite Capital’s core beliefs is that by combining machine learning, big data, and genomics, life sciences companies can accelerate commercialization from decades
Read More
How Support Automation Enhances Clinical Trial Management
The life of a clinical study relies on data from documentation, meetings, emails and calls; all of which can be overwhelming for patients, clinical trial teams and associates. Although mundane, documenting, executing and collecting data is crucial to move a trial from phase to phase.
Clinical trial teams face a multitude of competing priorities, from evaluating hundreds of potential patients to maintaining compliance and recording patient progress. No aspect or step can be neglected for a
Read More
